oxazoles has been researched along with Enterovirus Infections in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (8.33) | 18.7374 |
| 1990's | 3 (8.33) | 18.2507 |
| 2000's | 18 (50.00) | 29.6817 |
| 2010's | 12 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelnabi, R; Delang, L; Froeyen, M; Luyten, W; Ma, Y; Mirabelli, C; Neyts, J | 1 |
| DeBiasi, RL; Harik, N | 1 |
| Lv, W; Wang, Y; Zhang, M; Zhang, Y | 1 |
| Abzug, MJ | 2 |
| Fokine, A; Kihara, D; Kuhn, RJ; Liu, Y; Long, F; Meng, G; Rossmann, MG; Sheng, J; Shin, WH | 1 |
| Baggen, J; Delang, L; Froeyen, M; George, S; Hilgenfeld, R; Leyssen, P; Meijer, A; Neyts, J; Sun, L; Thibaut, HJ; van Kuppeveld, FJ; Vernachio, J; Zhang, L | 1 |
| Abzug, MJ; Acosta, EP; Cloud, G; Dennehy, P; Jacobs, RF; Jester, P; Kimberlin, D; Krogstad, P; Lawrence, R; Michaels, MG; Palmer, A; Robinson, J; Romero, JR; Sánchez, PJ; Shelton, M; Sood, SK; Storch, GA; Wald, E; Whitley, R; Wilson, G | 1 |
| Hernández, M | 1 |
| Muller, WJ | 1 |
| Makarov, VA; Riabova, OB; Schmidtke, M; Wutzler, P; Zieger, R | 1 |
| Cardosa, MJ; Lewthwaite, P; Ooi, MH; Solomon, T; Wong, SC | 1 |
| Cao, Q; Deng, Y; Ding, C; Feng, D; Gu, B; Hu, W; Wang, J; Xie, F; Yao, K; Zhang, C; Zhang, G; Zhou, F | 1 |
| Benschop, KS; Koen, G; Kuijpers, TW; van den Broek, PJ; Vossen, AC; Wierenga, PC; Wildenbeest, JG; Wolthers, KC | 1 |
| Sawyer, MH | 3 |
| Buscombe, JR; Johnson, MA; Thomson, AP; Tormey, VJ; Webster, AD | 1 |
| Abzug, MJ; Blount, S; Bradley, J; Capparelli, EV; Cloud, G; Kimberlin, DW; Lakeman, F; Lepow, M; Mani, C; Powell, D; Romero, J; Sánchez, PJ; Whitley, RJ | 1 |
| Andrews, PI; Bye, AM; Craig, ME; Lahra, MM; Nolan, MA; Prager, PC; Rawlinson, WD; Williams, GD | 1 |
| Andrews, IP; Nolan, M; Prager, P; Williams, GD | 1 |
| Webster, AD | 1 |
| Birch-Hirschfeld, E; Hammerschmidt, E; Makarov, VA; Riabova, OB; Schmidtke, M; Schüler, S; Wutzler, P; Zell, R | 1 |
| Byington, CL; Fujinami, RS; Libbey, JE; Rentz, AC; Whitby, FG | 1 |
| Accortt, NA; Desmond, RA; Soong, SJ; Talley, L; Villano, SA; Whitley, RJ | 1 |
| Rotbart, HA | 1 |
| Flückiger, U | 1 |
| Steele, RW; Yarush, LI | 1 |
| Abdel-Rahman, SM; Bradley, JS; Capparelli, EV; Jacobs, RF; James, LP; Johnson, KM; Kearns, GL | 1 |
| Forman, MS; Lederman, HM; Nowak-Wegrzyn, A; Phipatanakul, W; Winkelstein, JA | 1 |
| Rotbart, HA; Webster, AD | 1 |
| Romero, JR | 1 |
| Nigrovic, LE | 1 |
| Veckenstedt, A | 1 |
| Béládi, I; Dzeguse, D; Indulen, MK; Mécs, I; Veckenstedt, A; Zgórniak-Nowosielska, I | 1 |
| Guidinger, PL; Jubelt, B; McKinlay, MA; Ropka, SL; Wilson, AK | 1 |
12 review(s) available for oxazoles and Enterovirus Infections
| Article | Year |
|---|---|
Neonatal nonpolio enterovirus and parechovirus infections.
Topics: Antiviral Agents; Cross Infection; Enterovirus; Enterovirus Infections; Female; Fomites; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Oxadiazoles; Oxazoles; Parechovirus; Phenyl Ethers; Picornaviridae Infections; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious | 2018 |
The enteroviruses: problems in need of treatments.
Topics: Antiviral Agents; Drug Discovery; Enterovirus Infections; Global Health; Humans; Oxadiazoles; Oxazoles | 2014 |
Treatment of perinatal viral infections to improve neurologic outcomes.
Topics: Acyclovir; Antiviral Agents; Brain; Cognition; Cognition Disorders; Encephalitis, Herpes Simplex; Enterovirus Infections; Female; Ganciclovir; HIV Infections; Humans; Infant, Newborn; Nervous System Diseases; Oxadiazoles; Oxazoles; Pregnancy; Valganciclovir; Virus Diseases | 2017 |
Clinical features, diagnosis, and management of enterovirus 71.
Topics: Disease Management; Enterovirus A, Human; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles | 2010 |
Enterovirus infections: diagnosis and treatment.
Topics: Adult; Antiviral Agents; Child; Clinical Trials as Topic; Enterovirus Infections; Humans; Meningitis, Viral; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Virus Replication | 2002 |
Presentation, diagnosis, and management of enterovirus infections in neonates.
Topics: Adult; Antiviral Agents; Child; Enterovirus Infections; Humans; Infant, Newborn; Oxadiazoles; Oxazoles; Randomized Controlled Trials as Topic; Viral Vaccines | 2004 |
Pleconaril--an advance in the treatment of enteroviral infection in immuno-compromised patients.
Topics: Antiviral Agents; Enterovirus Infections; Humans; Immunocompromised Host; Oxadiazoles; Oxazoles; Poliovirus | 2005 |
Antiviral therapy for enteroviral infections.
Topics: Adult; Antiviral Agents; Enterovirus Infections; Humans; Immunization, Passive; Infant, Newborn; Oxadiazoles; Oxazoles; Randomized Controlled Trials as Topic | 1999 |
Enterovirus infections: diagnosis and treatment.
Topics: Antiviral Agents; Child; Cost of Illness; Enterovirus; Enterovirus Infections; Humans; Meningitis, Viral; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Serologic Tests | 1999 |
[On new antiviral drugs, new viruses and old known bacteria].
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Bacterial Infections; Enterovirus; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles; Virus Diseases; Viruses | 1999 |
Enterovirus infections: diagnosis and treatment.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Enterovirus Infections; Female; Humans; Infant; Infant, Newborn; Meningitis, Viral; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Sepsis | 2001 |
What's new with enteroviral infections?
Topics: Antiviral Agents; Cost-Benefit Analysis; Disease Outbreaks; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Romania; Scotland | 2001 |
6 trial(s) available for oxazoles and Enterovirus Infections
| Article | Year |
|---|---|
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.
Topics: Antiviral Agents; Double-Blind Method; Enterovirus; Enterovirus Infections; Female; Humans; Infant; Infant, Newborn; Male; Neonatal Sepsis; Oropharynx; Oxadiazoles; Oxazoles; Rectum | 2016 |
[A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis].
Topics: Antiviral Agents; Double-Blind Method; Enterovirus Infections; Female; Humans; Infant, Newborn; Male; Neonatal Sepsis; Oxadiazoles; Oxazoles; Placebo Effect; Reproducibility of Results; Time Factors; Treatment Outcome | 2016 |
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis.
Topics: Administration, Oral; Biological Availability; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enterovirus Infections; Female; Follow-Up Studies; Humans; Infant; Male; Meningitis, Viral; Oxadiazoles; Oxazoles; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2003 |
Enteroviral meningitis: natural history and outcome of pleconaril therapy.
Topics: Adult; Antiviral Agents; Double-Blind Method; Enterovirus Infections; Female; Headache; Humans; Male; Meningitis, Viral; Multivariate Analysis; Oxadiazoles; Oxazoles; Treatment Outcome | 2006 |
Single dose pharmacokinetics of pleconaril in neonates. Pediatric Pharmacology Research Unit Network.
Topics: Administration, Oral; Age Factors; Antiviral Agents; Area Under Curve; Biological Availability; Enterovirus Infections; Female; Humans; Infant, Newborn; Male; Oxadiazoles; Oxazoles | 2000 |
Treatment of potentially life-threatening enterovirus infections with pleconaril.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Chronic Disease; Enterovirus; Enterovirus Infections; Follow-Up Studies; Humans; Infant, Newborn; Meningoencephalitis; Middle Aged; Oxadiazoles; Oxazoles; Treatment Outcome | 2001 |
18 other study(ies) available for oxazoles and Enterovirus Infections
| Article | Year |
|---|---|
New class of early-stage enterovirus inhibitors with a novel mechanism of action.
Topics: Antiviral Agents; Capsid; Capsid Proteins; Cell Line; Cytopathogenic Effect, Viral; Drug Resistance, Viral; Drug Synergism; Enterovirus B, Human; Enterovirus Infections; Genotype; Humans; Molecular Conformation; Molecular Docking Simulation; Oxadiazoles; Oxazoles; para-Aminobenzoates; Protein Binding; RNA, Viral; Structure-Activity Relationship; Virus Replication | 2017 |
Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses.
Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Enterovirus; Enterovirus Infections; HeLa Cells; Humans; Isoxazoles; Luminescent Measurements; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Phenylalanine; Pyrrolidinones; Valine; Vero Cells | 2019 |
Structure and inhibition of EV-D68, a virus that causes respiratory illness in children.
Topics: Antiviral Agents; Capsid; Child; Crystallography, X-Ray; Enterovirus D, Human; Enterovirus Infections; Humans; Hydrophobic and Hydrophilic Interactions; Oxadiazoles; Oxazoles; Respiratory Tract Diseases; United States; Viral Proteins | 2015 |
Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68.
Topics: Antiviral Agents; Drug Resistance, Viral; Enterovirus D, Human; Enterovirus Infections; Humans; Microbial Sensitivity Tests; Models, Molecular; Oxadiazoles; Oxazoles; Receptors, Drug; Respiratory Tract Infections; Viral Proteins; Virus Replication | 2015 |
New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Topics: Antiviral Agents; Drug Design; Drug Resistance, Viral; Enterovirus B, Human; Enterovirus Infections; HeLa Cells; Humans; Isoxazoles; Mutation; Oxadiazoles; Oxazoles | 2009 |
In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection.
Topics: Animals; Animals, Newborn; Antiviral Agents; Cell Line, Tumor; Cell Survival; Child, Preschool; Disease Models, Animal; Enterovirus A, Human; Enterovirus Infections; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Ribavirin; Survival Analysis | 2012 |
Pleconaril revisited: clinical course of chronic enteroviral meningoencephalitis after treatment correlates with in vitro susceptibility.
Topics: Antiviral Agents; Cerebrospinal Fluid; Child; Chronic Disease; Drug Resistance, Viral; Enterovirus; Enterovirus Infections; Female; Humans; Immunoglobulins, Intravenous; Male; Meningoencephalitis; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; Treatment Outcome | 2012 |
SPECT scans for monitoring response to pleconaril therapy in chronic enteroviral meningoencephalitis.
Topics: Adolescent; Adult; Antiviral Agents; Common Variable Immunodeficiency; Enterovirus; Enterovirus Infections; Female; HIV Infections; Humans; Immunocompromised Host; Male; Meningoencephalitis; Oxadiazoles; Oxazoles; Tomography, Emission-Computed, Single-Photon | 2003 |
Survival after pulmonary edema due to enterovirus 71 encephalitis.
Topics: Acute Disease; Antiviral Agents; Child, Preschool; Combined Modality Therapy; Disease Outbreaks; Encephalitis, Viral; Enterovirus; Enterovirus Infections; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Infant; Magnetic Resonance Imaging; Male; New South Wales; Oxadiazoles; Oxazoles; Pulmonary Edema; Survival Analysis; Survivors | 2003 |
Neurogenic pulmonary edema in enterovirus 71 encephalitis is not uniformly fatal but causes severe morbidity in survivors.
Topics: Antiviral Agents; Child, Preschool; Echocardiography; Encephalitis, Viral; Enterovirus; Enterovirus Infections; Female; Follow-Up Studies; Humans; Infant; Intensive Care Units, Pediatric; Magnetic Resonance Imaging; Male; Oxadiazoles; Oxazoles; Pulmonary Edema; Respiration, Artificial; Time Factors | 2003 |
Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Topics: Amino Acid Substitution; Animals; Antiviral Agents; Capsid; Capsid Proteins; Cell Line; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Drug Resistance, Viral; Enterovirus B, Human; Enterovirus Infections; Humans; Hydrophobic and Hydrophilic Interactions; Oxadiazoles; Oxazoles; Polymorphism, Genetic | 2005 |
Investigation of treatment failure in neonatal echovirus 7 infection.
Topics: Antiviral Agents; Enterovirus B, Human; Enterovirus Infections; Fatal Outcome; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Molecular Sequence Data; Oxadiazoles; Oxazoles; Sequence Analysis, DNA; Treatment Failure | 2006 |
Diagnosis and prospective treatment of enteroviral infections in children.
Topics: Antiviral Agents; Child; Diagnosis, Differential; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral | 2000 |
Successful treatment of enterovirus infection with the use of pleconaril in 2 infants with severe combined immunodeficiency.
Topics: Antiviral Agents; Enterovirus Infections; Feces; Female; Humans; Infant; Oxadiazoles; Oxazoles; Polymerase Chain Reaction; RNA, Viral; Severe Combined Immunodeficiency | 2001 |
Pleconaril: a novel antipicornaviral drug.
Topics: Antiviral Agents; Clinical Trials as Topic; Enterovirus Infections; Humans; Oxadiazoles; Oxazoles | 2001 |
Effect of 3-[bis-(2-hydroxyethyl)-amino]-acetophenone-[4.5-diphenyl-oxazolyl-(2)]-hydrazone (IMET 98/69) on lethal mengo virus encephalitis.
Topics: Acetophenones; Administration, Oral; Animals; Antiviral Agents; Brain; Dose-Response Relationship, Drug; Encephalitis; Enterovirus Infections; Injections, Subcutaneous; Male; Mengovirus; Mice; Oxazoles | 1978 |
Antiviral effect of 3-[bis-(2-hydroxyethyl)-amino]-acetophenone-[4,5-diphenyl-oxyazolyl-(2)]hydrazone (IMET 98/69) in mice.
Topics: Administration, Oral; Animals; Antiviral Agents; Arbovirus Infections; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyocarditis virus; Enterovirus Infections; Female; Injections, Subcutaneous; Male; Mice; Orthomyxoviridae Infections; Oxazoles; RNA Viruses; Semliki forest virus; Vaccinia; Virus Diseases | 1979 |
Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril.
Topics: Animals; Antiviral Agents; Brain; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Microbial; Enterovirus Infections; Immunosuppression Therapy; Isoxazoles; Male; Mice; Mice, Inbred BALB C; Oxazoles; Poliomyelitis; Poliovirus | 1989 |